Information about a gene that helps define us as humans
University of Otago researchers have discovered information about a gene that sets primates - great apes and humans - apart from other mammals, through the study of a rare developmental brain disorder.

Brain organoids, or "mini-brains" growing in culture
Dr Adam O'Neill
Dr Adam O'Neill carried out the research as part of his PhD at the University of Otago, under the supervision of Professor Stephen Robertson, discovering that the PLEKHG6 gene has qualities that drives aspects of brain development differently in primates compared to other species.
"Broadly speaking, this gene can be thought of as one of the genetic factors that make us human in a neurological sense," Dr O'Neill who now works in the Department of Physiological Genomics at Ludwig Maximilian Universität in Munich, Germany, explains.
Professor Robertson says the research aimed to address the idea that there must be genes that humans have that have made our brains bigger and better functioning in some respects than other animals. However, that increased complexity could come at a cost, potentially predisposing humans to the development of a whole suite of neurological or psychiatric conditions.
"Such genes have been hard to find, but using an approach where we studied children with a certain brain malformation called periventricular nodular heterotopia, we found a 'damaged' genomic element in a child that had the attributes of such a primate specific genetic factor," he explains. In this particular condition a subset of neurons in the developing brain fail to take up their correct position resulting in a variety of symptoms including epilepsy and delayed development.
Dr O'Neill and research collaborators from Max Planck Institute of Psychiatry, Germany, then set forth to test the point that the gene drives aspects of brain development that are unique to primates. Some amazing data was found using a novel approach through studying human "mini-brains" in culture. It is now possible to take a skin cell and transform it using a set of genetic tricks, so that it can be triggered to form a tiny brain-like structure in culture in the lab.
Their results showed that the particular genetic change that disabled a component of this gene (PLEKHG6) altered its ability to support the growth and proliferation of specialised stem cells in the developing brain. In addition, some of these cells also failed to migrate to their correct position in the growing "mini-brain" during the first few weeks of brain development.
Professor Robertson says it has been known for a while that these stem cells behave differently between primates/humans and other animals, but understanding what genes regulate these differences has been a mystery.
"Adam's achievement has been to show that this particular component of the PLEKHG6 gene is one such regulator that humans have 'acquired' very recently in their evolution to make their brains 'exceptional'."
Dr O'Neill says there are very few genetic elements that are primate specific in our genome, so this discovery adds to a very short list of genetic factors that, at least in one sense, make us human.
"Such an understanding positions us to better understand how a brain builds itself- knowledge that will add to our ability to design strategies to repair the damaged brain, especially early in infancy where there are still lots of stem cells around," Dr O'Neill says.
The work also helps provide more information about the list of genes that are altered to cause this particular type of brain malformation.
"Personally, I also think it does underscore how it is very subtle nuanced differences that separate us from other animals. Our anthropocentrism could be a whole lot more humble," Dr O'Neill says.
Original publication
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Epistem's Biomarker Division Gains GCLP Accreditation
Henoch-Schönlein_purpura

Repelling disorder: What makes cholesterol-containing surfaces so repulsive? - The development of synthetic materials using the discovered principle is promising

A new path through the looking-glass - Innovative experimental scheme can create mirror molecules
Medicago receives regulatory approval to begin human clinical testing with its avian flu pandemic vaccine
Scientists Demystify an Enzyme Responsible for Drug and Food Metabolism
BioMérieux and Biocartis Sign Strategic Partnership in Molecular Diagnostics - Co-development of assays and co-distribution of a fully integrated molecular platform due for launch in 2012
Category:ZnMc_domain
Bovine_somatotropin
